Skip to content

A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00784641
Enrollment
567
Registered
2008-11-04
Start date
2008-11-30
Completion date
2009-01-31
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

Evaluation of the clinical performance of a novel Bausch & Lomb daily disposable contact lens when compared to the currently marketed Bausch & Lomb SofLens® daily disposable contact lenses and the currently marketed Johnson and Johnson 1-Day Acuvue Moist contact lenses when worn by adapted soft contact lens wearers on a daily disposable basis.

Interventions

DEVICENovel Bausch & Lomb daily disposable contact lenses

Lenses to be worn and replaced daily for 2 weeks.

DEVICEBausch & Lomb SofLens daily disposable contact lenses.

Lenses to be worn and replaced daily for 2 weeks.

DEVICEJohnson and Johnson 1-Day Acuvue Moist contact lenses

Lenses to be worn and replaced daily for 2 weeks.

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects with VA correctable to 0.3 logMAR (driving vision) or better in each eye. * Subjects must have clear central corneas and be free of any anterior segment disorders. * Subjects must be myopic and require lens correction in both eyes.

Exclusion criteria

* Subjects with any systemic disease affecting ocular health. * Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance. * Subjects wearing monovision, multifocal or toric contact lenses. * Subjects with grade 2 or greater slit lamp findings.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Favorable Responses for the Initial Lens Performance SurveyAt dispensingThe initial lens performance survey was administered at the Screening/Dispensing Visit. Scores were captured on a scale from 0 to 100, with 100 being the most favorable score. Favorable responses were defined as scores of 80 or greater.

Countries

United States

Participant flow

Recruitment details

There were 567 participants enrolled (1134 eyes).

Participants by arm

ArmCount
Novel Bausch & Lomb Contact Lens
Novel Bausch & Lomb daily disposable contact lenses Novel Bausch & Lomb daily disposable contact lenses: Lenses to be worn and replaced daily for 2 weeks.
188
SofLens
Bausch & Lomb SofLens daily disposable contact lenses Bausch & Lomb SofLens daily disposable contact lenses.: Lenses to be worn and replaced daily for 2 weeks.
186
Acuvue
Johnson and Johnson 1-Day Acuvue Moist contact lenses Johnson and Johnson 1-Day Acuvue Moist contact lenses: Lenses to be worn and replaced daily for 2 weeks.
187
Total561

Baseline characteristics

CharacteristicNovel Bausch & Lomb Contact LensSofLensAcuvueTotal
Age, Continuous32.8 years32.5 years32.5 years32.6 years
Sex: Female, Male
Female
147 Participants136 Participants137 Participants420 Participants
Sex: Female, Male
Male
41 Participants50 Participants50 Participants141 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 1890 / 1880 / 189
serious
Total, serious adverse events
0 / 1890 / 1880 / 189

Outcome results

Primary

Percentage of Participants With Favorable Responses for the Initial Lens Performance Survey

The initial lens performance survey was administered at the Screening/Dispensing Visit. Scores were captured on a scale from 0 to 100, with 100 being the most favorable score. Favorable responses were defined as scores of 80 or greater.

Time frame: At dispensing

Population: Eyes that were dispensed contact lenses are included in the analysis population.

ArmMeasureGroupValue (COUNT_OF_UNITS)
Novel Bausch & Lomb Contact LensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyLens handling upon insertion340 eyes
Novel Bausch & Lomb Contact LensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyBurning/stinging upon insertion363 eyes
Novel Bausch & Lomb Contact LensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyComfort333 eyes
Novel Bausch & Lomb Contact LensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyVision324 eyes
SofLensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyVision338 eyes
SofLensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyLens handling upon insertion293 eyes
SofLensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyComfort289 eyes
SofLensPercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyBurning/stinging upon insertion333 eyes
AcuvuePercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyVision363 eyes
AcuvuePercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyBurning/stinging upon insertion339 eyes
AcuvuePercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyComfort354 eyes
AcuvuePercentage of Participants With Favorable Responses for the Initial Lens Performance SurveyLens handling upon insertion326 eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026